In March 2025, the company announced new designs for any direct-to-shopper offering of its Wegovy weight loss drug. The company founded a whole new pharmacy, termed NovoCare, which would charge clients $499 per 30 days for entry to the drug, fewer than half the cost of the drug by other pharmaceutical distribution networks.[fifty three]Being famili